To access this element change to forms mode OFF
Grant Award View - GA990
FPR2 is a therapeutic target in lung cancer
GA ID:
GA990
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
24-Oct-2017
Publish Date:
30-Jan-2018
Category:
Medical Research
Grant Term:
1-Jan-2018 to 31-Dec-2021
Value (AUD):
$910,550.21
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 16/17 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
FPR2 is a therapeutic target in lung cancer
Purpose:
Lung cancer remains the biggest cause of cancer related deaths and chronic smoking is the major risk factor. We have recently demonstrated that a protein termed SAA contributes to damaging inflammation in chronic smokers that develop emphysema through activation of a receptor called FPR2. We will determine whether naturally derived products termed pro-resolving mediators that target this same FPR2 receptor will prove to be a novel and effective treatment for lung cancer.
Internal Reference ID:
GNT1142013
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
RMIT University
Recipient ABN:
49 781 030 034
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3000
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES